GLP-1 RAs, widely prescribed for T2DM and obesity, are increasingly used by women of reproductive age
Once a pen has been opened and used, it can be stored at room temperature or in the refrigerator for up to 30 days
Start your intake Clinical Safety Profiles: What the Evidence Shows Clinical trial data from major GLP-1 studies reveals adverse events typically cluster around gastrointestinal symptomsnausea, vomiting, and constipationoccurring in 2550% of patients at therapeutic doses
Decreased appetite and cravings, making it easier to maintain healthy eating habits
For someone weighing 100kg, thats 15-25kg lost over one year, roughly 110-240 per kg lost over the course of a year
25 Eli Lillys Retatrutide (GLP-1/GIP/Glucagon triple agonist) and Viking Therapeutics VK2735 (GLP-1/GIP dual agonist) are leading this charge